| Zacks Company Profile for Zynex Inc. (ZYXI : NSDQ) |
|
|
| |
| • Company Description |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Number of Employees: 774 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $7.19 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 514,423 shares |
| Shares Outstanding: 39.05 (millions) |
| Market Capitalization: $280.74 (millions) |
| Beta: 0.87 |
| 52 Week High: $16.26 |
| 52 Week Low: $4.97 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
0.84% |
10.08% |
| 12 Week |
6.20% |
14.78% |
| Year To Date |
-20.67% |
-6.04% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
9655 MAROON CIRCLE
-
ENGLEWOOD,CO 80112
USA |
ph: 303-703-4906
fax: - |
info@zynex.com |
http://www.zynex.com |
|
|
| |
| • General Corporate Information |
Officers
Thomas Sandgaard - Chairman; President; Chief Executive Officer and P
Daniel Moorhead - Chief Financial Officer and Principal Financial Of
Barry D. Michaels - Director
Michael Cress - Director
- - -
|
|
Peer Information
Zynex Inc. (BJCT)
Zynex Inc. (CADMQ)
Zynex Inc. (APNO)
Zynex Inc. (UPDC)
Zynex Inc. (IMTIQ)
Zynex Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 98986M103
SIC: 3845
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding: 39.05
Most Recent Split Date: 1.00 (1.10:1)
Beta: 0.87
Market Capitalization: $280.74 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.07 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $0.44 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 4.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
